Focal hepatic lesions: Contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent

Korean Journal of Radiology

Volumn 4, Issue 4, 2003, Pages 224-233

  Kim, Eun A ^a   Yoon, Kwon Ha ^a   Lee, Young Hwan ^a   Kim, Hye Won ^a   Juhng, Seon Kwan ^a   Won, Jong Jin ^a  

^a Wonkwang University   (South Korea)

Author keywords

Liver neoplasms; Liver, neoplasms; Liver, US; Ultrasound (US), contrast media; Ultrasound (US), harmonic study; US microbubbles

Indexed keywords

CONTRAST MEDIUM; MICROBUBBLE CONTRAST AGENT; UNCLASSIFIED DRUG;

ACOUSTICS; ADULT; AGED; CANCER PATIENT; CLASSIFICATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEMANGIOMA; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INJECTION; LIVER CELL CARCINOMA; LIVER INJURY; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTION; PULSE INVERSION HARMONIC ULTRASOUND; REVIEW; TIME; TUMOR VASCULARIZATION;

EID: 2342622727     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2003.4.4.224     Document Type: Review

References (21)

1. Choi BI, Kim TK, Han JK, Chung JW, Park JH, Han MC. Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors. Radiology 1996;200:55-58
2. Lencioni R, Pinto F, Armillotta N, Bartolozzi C. Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US. Radiology 1996;201:353-358
3. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996;51:50-55
4. Goldberg BB, Liu J, Burns PN, Merton DA, Forsberg F. Galactose-based intravenous sonographic contrast agent: experimental studies. J Ultrasound Med 1993;12:463-470
5. Cosgrove D. Why do we need contrast agents for ultrasound? Clin Radiol 1996;51:1-4
6. Schineider M, Broillet A, Bussat P, et al. Gray-scale liver enhancement in VX2 tumor-bearing rabbits using BR14, a new ultrasonographic contrast agent. Invest Radiol 1997;32:410-417
7. Forsberg F, Goldberg BB, Liu J, Merton DA, Rawool NM, Shi WT. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology 1999;210:125-132
8. Hauff, PD, Fritzsch TD, Reinhardt M, et al. Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 1997;32:94-99
9. Kono Y, Moriyasu F, Nada T, et al. Gray scale second harmonic imaging of the liver: a preliminary animal study. Ultrasound Med Biol 1997;23:719-726
10. Burns PN, Wilson SR, Simpson DH. Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000;35:58-71
11. Wilson SR, Burns PN, Muradali D, Wilson JA, Lai X. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis. Radiology 2000;215:153-161
12. Blomley MJK, Albrecht T, Cosgrove DO, et al. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology 1999;210:409-416
13. Dalla-Palma L, Bertolotto M, Quaia E, Locatelli M. Detection of liver metastases with pulse-inversion harmonic imaging: preliminary results. Eur Radiol 1999;9:382-387
14. Kim TK, Choi BI, Han JK, Hong HS, Park SH, Moon SG. Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US. Radiology 2000;216:411-417
15. Jang HJ, Lim HK, Lee WJ, et al. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US. Korean J Radiol 2003;4:91-100
16. Dill-Macky MJ, Burns PN, Khalili K, Wilson SR. Focal hepatic masses: enhancement patterns with SH U 508A and pulse-inversion US. Radiology 2002;222:95-102
17. Albrecht T, Hoffmann CW, Schmitz S, et al. Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases. AJR Am J Roentgenol 2001;176:1191-1198
18. Blomley MJK, Albrecht T, Cosgrove DO, et al. Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist® in normal volunteers and patients with and without liver disease. Ultrasound Med Biol 1999;25:1341-1352
19. Ko CJ, Yoon KH. Gray-scale stimulated acoustic emission: differential diagnosis between hepatocellular carcinoma and metastatic adenocarcinoma. J Korean Radiol Soc 2001;44:63-68
20. Yamashita Y, Ogata I, Urata J, Takahashi M. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology 1997;203:121-125
21. Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995;197:329-337